{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:59:17Z","timestamp":1754398757929},"reference-count":72,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.beha.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T11:04:57Z","timestamp":1369307097000},"page":"33-41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["NK\/T-cell lymphomas in children"],"prefix":"10.1016","volume":"26","author":[{"given":"Catherine","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieron","family":"Dunleavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.04.004_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"23","key":"10.1016\/j.beha.2013.04.004_bib2","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1158\/1078-0432.CCR-09-1995","article-title":"New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies","volume":"16","author":"Dunleavy","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.beha.2013.04.004_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.beha.2013.04.004_bib5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM197812282992606","article-title":"Childhood non-Hodgkin's lymphoma","volume":"299","author":"Murphy","year":"1978","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beha.2013.04.004_bib6","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2008.400","article-title":"Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study","volume":"23","author":"Sandlund","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.22162","article-title":"Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology","volume":"53","author":"Pillon","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","article-title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial","volume":"44","author":"Uyttebroeck","year":"2008","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.beha.2013.04.004_bib10","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V80.10.2471.2471","article-title":"Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group","volume":"80","author":"Reiter","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.004_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pbc.24149","article-title":"Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group","volume":"59","author":"Termuhlen","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib12","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.004_bib13","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.beha.2013.04.004_bib14","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2008.21.1318","article-title":"Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group","volume":"27","author":"Coustan-Smith","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3324\/haematol.12327","article-title":"Tumor lysis syndrome: current perspective","volume":"93","author":"Hochberg","year":"2008","journal-title":"Haematologica"},{"issue":"18","key":"10.1016\/j.beha.2013.04.004_bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin's lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","article-title":"Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","article-title":"Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma","volume":"24","author":"Burkhardt","year":"2006","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.beha.2013.04.004_bib19","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.beha.2013.04.004_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1984.2.9.979","article-title":"High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas","volume":"2","author":"Hartmann","year":"1984","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","article-title":"BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma","volume":"13","author":"Mills","year":"1995","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2013.04.004_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00277-006-0169-2","article-title":"Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: a report from the Korean society of pediatric hematology-oncology","volume":"85","author":"Won","year":"2006","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ejh.12019","article-title":"A novel TRB@\/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34)","volume":"90","author":"Yamamoto","year":"2013","journal-title":"Eur J Haematol"},{"issue":"16","key":"10.1016\/j.beha.2013.04.004_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib25","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia\/lymphoma","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib26","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2008-03-147587","article-title":"K-RasG12D-induced T-cell lymphoblastic lymphoma\/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors","volume":"112","author":"Kindler","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2013.04.004_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/leu.2011.20","article-title":"Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia","volume":"25","author":"Evangelisti","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.leukres.2011.10.022","article-title":"Synergistic activity of rapamycin and dexamethasone in\u00a0vitro and in\u00a0vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis","volume":"36","author":"Zhang","year":"2012","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.beha.2013.04.004_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood-2009-07-233445","article-title":"A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia\/lymphoma","volume":"115","author":"Lin","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib30","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2013.04.004_bib31","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","article-title":"Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity","volume":"86","author":"Shiota","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1182\/blood.V87.1.284.284","article-title":"High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining","volume":"87","author":"Lamant","year":"1996","journal-title":"Blood"},{"issue":"5151","key":"10.1016\/j.beha.2013.04.004_bib33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib34","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2013.04.004_bib35","first-page":"3509","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK","volume":"94","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2013.04.004_bib36","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","article-title":"Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis","volume":"17","author":"Bischof","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.beha.2013.04.004_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib38","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","article-title":"Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"97","author":"Seidemann","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2013.04.004_bib39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1365-2141.1999.01238.x","article-title":"Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases","volume":"104","author":"Bayle","year":"1999","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2013.04.004_bib40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.1994.12.5.895","article-title":"Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma","volume":"12","author":"Sandlund","year":"1994","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib41","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1200\/JCO.2005.11.075","article-title":"Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial","volume":"23","author":"Laver","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.beha.2013.04.004_bib43","first-page":"3591","article-title":"CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology","volume":"92","author":"Brugieres","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2013.04.004_bib44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","article-title":"Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pbc.21817","article-title":"Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941","volume":"52","author":"Lowe","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.beha.2013.04.004_bib46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1200\/JCO.1994.12.5.899","article-title":"Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies","volume":"12","author":"Reiter","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.004_bib47","first-page":"1618","article-title":"DA-EPOCH chemotherapy is highly effective in ALK-positive and ALK-negative ALCL: results of a prospective study of PTCL subtypes in adults","volume":"118","author":"Dunleavy","year":"2011","journal-title":"Blood (ASH Annu Meet Abstr)"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib48","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood.V84.8.2467.2467","article-title":"Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35)","volume":"84","author":"Sandlund","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2013.04.004_bib49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage\u2013a report of the Berlin-Frankfurt-Munster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"issue":"30","key":"10.1016\/j.beha.2013.04.004_bib50","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1200\/JCO.2008.20.1764","article-title":"Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1008352726155","article-title":"Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children\u2013a report from the French Society of Pediatric Oncology","volume":"11","author":"Brugieres","year":"2000","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0609.2005.00422.x","article-title":"Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series","volume":"75","author":"Cesaro","year":"2005","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2013.04.004_bib53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2006.06004.x","article-title":"Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents\u2013a Berlin-Frankfurt-Munster group report","volume":"133","author":"Woessmann","year":"2006","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.beha.2013.04.004_bib54","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2011.34.8417","article-title":"Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study","volume":"29","author":"Woessmann","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2013.04.004_bib55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1158\/1078-0432.CCR-09-2069","article-title":"Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate","volume":"16","author":"Okeley","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.beha.2013.04.004_bib56","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood-2007-07-099317","article-title":"A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies","volume":"111","author":"Bartlett","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.beha.2013.04.004_bib57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"Younes","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.beha.2013.04.004_bib58","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1021\/jm201550q","article-title":"Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase","volume":"55","author":"Gingrich","year":"2012","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMc1013224","article-title":"Crizotinib in anaplastic large-cell lymphoma","volume":"364","author":"Gambacorti-Passerini","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.beha.2013.04.004_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.21543","article-title":"Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study","volume":"51","author":"Hutchison","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/MPH.0b013e3182707592","article-title":"Peripheral T-cell lymphoma in children and adolescents: a single-institution experience","volume":"34","author":"Al Mahmoud","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"10.1016\/j.beha.2013.04.004_bib62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0046-8177(90)90148-X","article-title":"Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases","volume":"21","author":"Chott","year":"1990","journal-title":"Hum Pathol"},{"issue":"25","key":"10.1016\/j.beha.2013.04.004_bib63","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beha.2013.04.004_bib64","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2013.04.004_bib65","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1182\/blood.V80.11.2938.2938","article-title":"Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents","volume":"80","author":"Gordon","year":"1992","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.beha.2013.04.004_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199409049645","article-title":"Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation","volume":"14","author":"Gordon","year":"1994","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"10.1016\/j.beha.2013.04.004_bib67","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2013.04.004_bib68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MPH.0b013e318168e7f7","article-title":"The primary role of the otolaryngologist in managing pediatric sinonasal malignancies: an extranodal NK\/T-cell lymphoma originating from the inferior turbinate mucosa of the nasal cavity","volume":"30","author":"Lee","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.beha.2013.04.004_bib69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3816\/CLML.2010.n.021","article-title":"Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review","volume":"10","author":"Ochenrider","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"10.1016\/j.beha.2013.04.004_bib70","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.leu.2400742","article-title":"Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma","volume":"11","author":"Alonsozana","year":"1997","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.beha.2013.04.004_bib71","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/annonc\/mdq698","article-title":"A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides\/Sezary syndrome","volume":"22","author":"Jacobsen","year":"2011","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.beha.2013.04.004_bib72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MPH.0b013e31817588e8","article-title":"Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol","volume":"30","author":"Medhi","year":"2008","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T21:55:36Z","timestamp":1688248536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1521692613000054"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.004","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK\/T-cell lymphomas in children","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}